This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, G.
Right arrow Articles by Taylor, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, G.
Right arrow Articles by Taylor, D. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, August 1998, p. 1952-1958, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Site-Specific Mutations in the 23S rRNA Gene of Helicobacter pylori Confer Two Types of Resistance to Macrolide-Lincosamide-Streptogramin B Antibiotics

Ge Wang and Diane E. Taylor*

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada

Received 12 November 1997/Returned for modification 1 January 1998/Accepted 28 May 1998

Clarithromycin resistance in Helicobacter pylori is mainly due to A-to-G mutations within the peptidyltransferase region of the 23S rRNA. In the present study, cross-resistance to macrolide, lincosamide, and streptogramin B (MLS) antibiotics (MLS phenotypes) has been investigated for several clinical isolates of H. pylori. Two major types of MLS resistance were identified and correlated with specific point mutations in the 23S rRNA gene. The A2142G mutation was linked with high-level cross-resistance to all MLS antibiotics (type I), and the A2143G mutation gave rise to an intermediate level of resistance to clarithromycin and clindamycin but no resistance to streptogramin B (type II). In addition, streptogramin A and streptogramin B were demonstrated to have a synergistic effect on both MLS-sensitive and MLS-resistant H. pylori strains. To further understand the mechanism of MLS resistance in H. pylori, we performed in vitro site-directed mutagenesis (substitution of G, C, or T for A at either position 2142 or 2143 of the 23S rRNA gene). The site-directed point mutations were introduced into a clarithromycin-susceptible strain, H. pylori UA802, by natural transformation followed by characterization of their effects on MLS resistance in an isogenic background. Strains with A-to-G and A-to-C mutations at the same position within the 23S rRNA gene had similar levels of clarithromycin resistance, and this level of resistance was higher than that for strains with the A-to-T mutation. Mutations at position 2142 conferred a higher level of clarithromycin resistance than mutations at position 2143. All mutations at position 2142 conferred cross-resistance to all MLS antibiotics, which corresponds to the type I MLS phenotype, whereas mutations at position 2143 were associated with a type II MLS phenotype with no resistance to streptogramin B. To explain that A-to-G transitions were predominantly observed in clarithromycin-resistant clinical isolates, we propose a possible mechanism by which A-to-G mutations are preferentially produced in H. pylori.


* Corresponding author. Mailing address: Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada T6G 2H7. Phone: (403) 492-4777. Fax: (403) 492-7521. E-mail: diane.taylor{at}ualberta.ca.


Antimicrobial Agents and Chemotherapy, August 1998, p. 1952-1958, Vol. 42, No. 8
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Lai, C.-H., Kuo, C.-H., Chen, P.-Y., Poon, S.-K., Chang, C.-S., Wang, W.-C. (2006). Association of antibiotic resistance and higher internalization activity in resistant Helicobacter pylori isolates. J Antimicrob Chemother 57: 466-471 [Abstract] [Full Text]  
  • Gibreel, A., Kos, V. N., Keelan, M., Trieber, C. A., Levesque, S., Michaud, S., Taylor, D. E. (2005). Macrolide Resistance in Campylobacter jejuni and Campylobacter coli: Molecular Mechanism and Stability of the Resistance Phenotype. Antimicrob. Agents Chemother. 49: 2753-2759 [Abstract] [Full Text]  
  • Burucoa, C., Landron, C., Garnier, M., Fauchere, J.-L., Khan, R., Rahman, M. (2005). T2182C Mutation Is Not Associated with Clarithromycin Resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 49: 868-870 [Full Text]  
  • Kuijper, E. J., Stevens, S., Imamura, T., de Wever, B., Claas, E. C. J. (2003). Genotypic Identification of Erythromycin-Resistant Campylobacter Isolates as Helicobacter Species and Analysis of Resistance Mechanism. J. Clin. Microbiol. 41: 3732-3736 [Abstract] [Full Text]  
  • Bartkus, J. M., Juni, B. A., Ehresmann, K., Miller, C. A., Sanden, G. N., Cassiday, P. K., Saubolle, M., Lee, B., Long, J., Harrison, A. R. Jr., Besser, J. M. (2003). Identification of a Mutation Associated with Erythromycin Resistance in Bordetella pertussis: Implications for Surveillance of Antimicrobial Resistance. J. Clin. Microbiol. 41: 1167-1172 [Abstract] [Full Text]  
  • Fontana, C., Favaro, M., Minelli, S., Criscuolo, A. A., Pietroiusti, A., Galante, A., Favalli, C. (2002). New Site of Modification of 23S rRNA Associated with Clarithromycin Resistance of Helicobacter pylori Clinical Isolates. Antimicrob. Agents Chemother. 46: 3765-3769 [Abstract] [Full Text]  
  • Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., Berg, D. E. (2002). Emergence of Tetracycline Resistance in Helicobacter pylori: Multiple Mutational Changes in 16S Ribosomal DNA and Other Genetic Loci. Antimicrob. Agents Chemother. 46: 3940-3946 [Abstract] [Full Text]  
  • Pereyre, S., Gonzalez, P., de Barbeyrac, B., Darnige, A., Renaudin, H., Charron, A., Raherison, S., Bebear, C., Bebear, C. M. (2002). Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis. Antimicrob. Agents Chemother. 46: 3142-3150 [Abstract] [Full Text]  
  • Ng, L.-K., Martin, I., Liu, G., Bryden, L. (2002). Mutation in 23S rRNA Associated with Macrolide Resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46: 3020-3025 [Abstract] [Full Text]  
  • Sander, P., Springer, B., Prammananan, T., Sturmfels, A., Kappler, M., Pletschette, M., Bottger, E. C. (2002). Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations. Antimicrob. Agents Chemother. 46: 1204-1211 [Abstract] [Full Text]  
  • Wang, G., Wilson, T. J. M., Jiang, Q., Taylor, D. E. (2001). Spontaneous Mutations That Confer Antibiotic Resistance in Helicobacter pylori. Antimicrob. Agents Chemother. 45: 727-733 [Abstract] [Full Text]  
  • Vester, B., Douthwaite, S. (2001). Macrolide Resistance Conferred by Base Substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45: 1-12 [Full Text]  
  • Depardieu, F., Courvalin, P. (2001). Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 45: 319-323 [Abstract] [Full Text]  
  • Wang, G., Rahman, M. S., Humayun, M. Z., Taylor, D. E. (1999). Multiplex Sequence Analysis Demonstrates the Competitive Growth Advantage of the A-to-G Mutants of Clarithromycin-Resistant Helicobacter pylori. Antimicrob. Agents Chemother. 43: 683-685 [Abstract] [Full Text]  
  • García-Arata, M. I., Baquero, F., de Rafael, L., de Argila, C. M., Gisbert, J. P., Bermejo, F., Boixeda, D., Cantón, R. (1999). Mutations in 23S rRNA in Helicobacter pylori Conferring Resistance to Erythromycin Do Not Always Confer Resistance to Clarithromycin. Antimicrob. Agents Chemother. 43: 374-376 [Abstract] [Full Text]